Strand, V., Kremer, J., Wallenstein, G., Kanik, K. S., Connell, C., Gruben, D., . . . Fleischmann, R. (2015). Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs. Arthritis Res Ther.

Strand, Vibeke, Joel Kremer, Gene Wallenstein, Keith S. Kanik, Carol Connell, David Gruben, Samuel H. Zwillich, i Roy Fleischmann. "Effects of Tofacitinib Monotherapy On Patient-reported Outcomes in a Randomized Phase 3 Study of Patients With Active Rheumatoid Arthritis and Inadequate Responses to DMARDs." Arthritis Res Ther 2015.

Strand, Vibeke, et al. "Effects of Tofacitinib Monotherapy On Patient-reported Outcomes in a Randomized Phase 3 Study of Patients With Active Rheumatoid Arthritis and Inadequate Responses to DMARDs." Arthritis Res Ther 2015.